Australia and New Zealand Remote Healthcare Market Growth Drivers and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Australia and New Zealand Remote Healthcare Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Service (Real Time Virtual Health, Remote Patient Monitoring, and Tele-ICUs); and End-User (Healthcare Providers, Patients, Payers, Employer Groups and Government Organizations)

  • Report Date : Dec 2022
  • Report Code : TIPRE00029787
  • Category : Technology, Media and Telecommunications
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 132
Page Updated: Jan 2023

The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021 and is expected to reach US$ 8,317.66 million by 2028; it is anticipated to record a CAGR of 27.3% from 2022 to 2028.

Remote health is revolutionizing the healthcare industry and can be seen as a subset of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time. Moreover, it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.

The growth of the Australia and New Zealand remote healthcare market is attributed to the factors such as rise in the use of telehealth and virtual care during the COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns are hampering the market growth.

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Increase in Number of Digital Health Users

People in Australia and New Zealand are already using digital apps, tools, and services as the preferred way to manage their personal and professional lives. Telehealth remains a constant part of Australia’s health system, which has enhanced access to quality health care for Australians. More than 100 million telehealth services have been provided to 17 million Australians since March 2020. Digital health is an umbrella term indicating a range of technologies that can be used to treat patients and gather and share a person’s health information. Digital health includes mobile health, electronic prescribing, electronic health records, telemedicine and telehealth, and robotics and artificial intelligence.

According to the Australian Digital Health Agency (ADHA) statistics, the number of records with data in them on My Health Record grew from 5.39 million in January 2019 to 22.31 million in December 2021, with more than 537 million documents uploaded. Monthly views of content on the platform were 476% higher between July and December 2021 (6.08 million avg/month) compared with pre-pandemic views from March 2019 to February 2020 (1.06 million avg/month).

Now and in the future, high-quality digital information remains an important aspect of health care. In particular, improving standardizing and health data development could lead to better information to use and share within the health care system. Thus, the improving user experience in digital health is expected to catalyze the growth of the Australia and New Zealand remote healthcare market.

The COVID-19 outbreak positively impacted the growth of the remote healthcare market in Asia Pacific. The Government of Australia expanded Australians' access to telehealth in March 2020 to minimize the risk of community transmission. Over 200 telehealth services were made permanently available. The MBS video and telephone services are available nationally from medical specialists, GPs, and other health professionals. In July 2022, a new temporary telehealth service was introduced that allows longer telephone consultations for patients who have received a positive COVID-19 test. Also, virtual health care (VHC) COVID-19 home monitoring for patients with mild to moderate illness was adopted as a central strategy in Australia to reduce pressure away from acute health systems. Thus, the growing government support for remote patient monitoring for the treatment of COVID-19 is supporting the Australia and New Zealand remote healthcare market.

Service-Based Insights

Based on service, the remote healthcare market is segmented into real time virtual health, remote patient monitoring, and tele-ICUs. The remote patient monitoring segment held the largest market share in 2021. However, the real time virtual health segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028). Remote patient monitoring (RPM) is a method of healthcare delivery through digital health platforms that enables patients to be evaluated outside traditional healthcare settings, in their homes, or community. RPM can significantly reduce a patient's time in the hospital and allow them to recover under monitoring at home. RPM is especially effective for chronic conditions such as heart disease, chronic obstructive pulmonary disease (COPD), and asthma. Also, a rise in product development is likely to favor the market growth. During the pandemic, “COVIDWatch” was developed by the University of Pennsylvania's health system. It is an RPM program that uses automated twice-daily short message service questionnaires to track symptoms.

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
End User-Based Insights

Based on end user, the remote healthcare market is segmented into healthcare providers, patients, payers, and employer groups & government organizations. The healthcare providers segment held the largest share of the market in 2021. However, the payers segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028).

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Australia and New Zealand Remote Healthcare Market: Strategic Insights

australia-and-new-zealand-remote-healthcare-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Various companies in the Australia and New Zealand remote healthcare market focus on the collaboration strategy to expand their clientele, which, in turn, helps them maintain their brand name across the world.

The Australia and New Zealand remote healthcare market is segmented based on service and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and tele-ICU. In terms of end user, the market is segmented into healthcare providers, patients, payers, and employer groups and government organizations.

Company Profiles

  • BIOTRONIK SE & Co KG
  • Koninklijke Philips NV
  • Hicuity Health Inc
  • Medtronic Plc
  • American Well Corp
  • Teladoc Health Inc
  • BioTelemetry Inc
  • Abbott Laboratories
  • GE HealthCare
  • Siemens Healthcare GmbH
Report Scope

Australia and New Zealand Remote Healthcare Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1,545.82 Million
Market Size by 2028 US$ 8,317.66 Million
Global CAGR (2022 - 2028) 27.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Service
  • Real Time Virtual Health
  • Remote Patient Monitoring
  • Tele-ICUs
By End-User
  • Healthcare Providers
  • Patients
  • Payers
  • Employer Groups and Government Organizations
Regions and Countries Covered Australia
  • Australia
Market leaders and key company profiles
  • BIOTRONIK SE & Co KG
  • Koninklijke Philips NV
  • Hicuity Health Inc
  • Medtronic Plc
  • American Well Corp
  • Teladoc Health Inc
  • BioTelemetry Inc
  • Abbott Laboratories
  • GE HealthCare

  • Australia and New Zealand Remote Healthcare Market Players Density: Understanding Its Impact on Business Dynamics

    The Australia and New Zealand Remote Healthcare Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    australia-and-new-zealand-remote-healthcare-market-cagr

    • Get the Australia and New Zealand Remote Healthcare Market top key players overview

    Frequently Asked Questions

    1

    What is remote healthcare?

    Remote health is revolutionizing the healthcare industry and can be seen as a sub-set of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time, along with which it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.
    2

    What are the driving factors for the Australia and New Zealand remote healthcare market?

    The factors that are driving the growth of market are rise in use of telehealth and virtual care during COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns is the major factor hindering the remote healthcare market growth.
    3

    Who are the major players in Australia and New Zealand remote healthcare market?

    The remote healthcare market majorly consists of the players, such as BIOTRONIK SE & Co KG, Koninklijke Philips NV, Hicuity Health Inc, Medtronic Plc, American Well Corp, Teladoc Health Inc, BioTelemetry Inc, Abbott Laboratories, GE HealthCare, and Siemens Healthcare GmbH among others.
    4

    What will be the CAGR of the Australia and New Zealand remote healthcare market during the forecast period?

    The market is estimated to grow at a CAGR of 27.3% during the forecast period.
    5

    What was the estimated Australia and New Zealand remote healthcare market size in 2021?

    The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021.
    6

    What are the growth estimates for the Australia and New Zealand remote healthcare market till 2028?

    The Australia and New Zealand remote healthcare market is expected to reach US$ 8,317.66 million by 2028.
    7

    Which segment is dominating the Australia and New Zealand remote healthcare market based on service?

    The Australia and New Zealand remote healthcare market is analyzed based on service type and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and Tele-ICUs. In 2021, the remote patient monitoring segment held the largest share of the market. However, the real time virtual health segment is anticipated to register the highest CAGR during the forecast period.
    8

    Which country accounts for major market share in 2021 in Australia and New Zealand remote healthcare market?

    Australia accounts for the major market share of remote healthcare market in 2021 due to increasing aging population and rising prevalence of chronic illnesses.
    Ankita Mittal
    Manager,
    Market Research & Consulting

    Ankita is a dynamic market research and consulting professional with over 8 years of experience across the technology, media, ICT, and electronics & semiconductor sectors. She has successfully led and delivered 100+ consulting and research assignments for global clients such as Microsoft, Oracle, NEC Corporation, SAP, KPMG, and Expeditors International. Her core competencies include market assessment, data analysis, forecasting, strategy formulation, competitive intelligence, and report writing.

    Ankita is adept at handling complete project cycles—from pre-sales proposal design and client discussions to post-sales delivery of actionable insights. She is skilled in managing cross-functional teams, structuring complex research modules, and aligning solutions with client-specific business goals. Her excellent communication, leadership, and presentation abilities have enabled her to consistently deliver value-driven outcomes in fast-paced and evolving market environments.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo